Pain, Opioids and the EMR. Dr. Gordon Schacter April 12, 2018

Similar documents
Increase in Opioid Related Deaths What the Data Can Tell us. Ontario Methadone Prescriber s Conference November 7, 2014 Tara Gomes

Partnered Efforts in Safe Opioid Prescribing

Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care)

Knock Out Opioid Abuse in New Jersey:

Opioid Prescribing for Acute Pain. Care for People 15 Years of Age and Older

Approaches to Responsible Opioid Prescribing. The Opioid Naïve Patient

Opioids and Chronic Pain: Case studies and Personal Experience

NBPDP Drug Utilization Review Process Update

CDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control

New Guidelines for Prescribing Opioids for Chronic Pain

SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP)

Management of Pain - A Comparison of Current Guidelines

2017 Opioid Guideline Update

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

Management of Chronic Non Cancer Pain Tool Instruction Manual for Practice Solutions Electronic Medical Record Intended Tool Use

Narcotics Monitoring System (NMS) Update

Learn how MORPHABOND ER can help manage your pain

Building capacity for a CHC response to Ontario's Opioid Crisis

Community Opioid Load: Concept to Action in Kingston-KFLA

Summary of Recommendations...3. PEG: A Three-Item Scale Assessing Pain (Appendix A) Chronic Pain Flow Sheet Acute Pain Flow Sheet...

Recommendations in Opioid Prescribing Guidelines for Chronic Pain

Jennifer Wyman, MD, Academic Lead, Opioids Clinical Primer Assistant Professor, Dept. of Family & Community Medicine, University of Toronto

Opioid Review and MAT Clinic CDC Guidelines

CDC Guideline for Prescribing Opioids for Chronic Pain

Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain

MOA: Practice Managers Program. Presented by: Kimber Debelak, CMC, CMOM, CMIS. May 17, zpain Management. & New Opioid Laws

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment

Improving emergency department management of acute opioid withdrawal

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

Proposed Revision to Med (i)

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Pregabalin. For the Treatment of Pain

Treating pain without pills

The Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM

Prior Authorization Guideline

Section I. Short-acting opioid Prior Authorization Criteria

Opioid Prescribing Tips & Tricks CANDY STOCKTON, MD MAY 2018

The STOP Measure. Safe and Transparent Opioid Prescribing to Promote Patient Safety and Reduced Risk of Opioid Misuse FEBRUARY 2018

Prescribing Opioids in the Opioid Epidemic. Scott Woffinden, PA-C Jason Chapman, JD

Opiate Use Disorder and Opiate Overdose

Changing the Tide. An EMR facilitated process supporting safe and effective prescribing and de-prescribing of controlled drugs

6/6/2017. Faculty/Presenter Disclosure. Disclosure of Commercial Support

Drug Overdoses A Public Health Problem. Marianne Cloeren, MD, MPH, FACOEM, FACP 10/2/2013. Objectives

MEDICALLY ASSISTED TREATMENT IN PROBLEMATIC OPIOID Punta Cana 2018

Safe Prescribing of Drugs with Potential for Misuse/Diversion

Opioid Prescribing for Acute Pain

Readopt with amendment Med 502, effective (Document #11090), to read as follows:

California. Prescribing and Dispensing Profile. Research current through November 2015.

Prescribing drugs of dependence in general practice, Part C

THE PROS & CONS OF THE CDC GUIDELINES FOR SAFE OPIOID PRESCRIBING

THE UNSTABLE BUPRENORPHINE- NALOXONE PATIENT

Prescription Opioid Addiction

Management of high risk MMT patients. Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013

Controlled Substances: A survey of tools and resources required by hospital pharmacists

Welcome - we will begin the webinar shortly Please read the participation tips below:

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Models of good practice in drug treatment in Europe. Project group

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Prescription Review Program and College Expectations

The Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM

Post-Stroke Mood & Anxiety Disorder Clinic

SAFE PRESCRIBING: RULES AND REGULATIONS. Michelle Y. Owens, MD MS State Board of Medical Licensure June 30, 2017

Universal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?

Slow Release Opioids. Morphine (Zomorph/MST) Oxycodone (Longtec, Oxycontin) Tapentadol (Palexia) For the Treatment of Pain

The Challenging Patient with Chronic Opioid Usage MD ACP Meeting

Clinical and Contextual Evidence Reviews

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

New Guidelines for Opioid Prescribing

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit

POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE

Mindful Prescribing for Acute Pain

Teaming Up for Safer Pain Management: Strategies for Effective Collaboration

OLDER ADULTS & DEPRESCRIBING: TREATMENT

Department of Veterans Affairs Network Policy No.: VA Desert Pacific Healthcare Network (VISN 22) Date: September 23, 2014 Long Beach, CA

Chronic Pain Pharmacist role in the clinic

Chronic Pain Management in the Primary Care Setting

Opioid dependence: Detoxification

Scope of the Opiate Problem 6/5/18. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond. Overview.

Opioids in the Management of Chronic Pain: An Overview

Analgesics: Management of Pain In the Elderly Handout Package

GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline

Non Opioid Approaches to Pain and Musculoskeletal Disorders KEVIN ODONNELL, DO FLAGSTAFF BONE AND JOINT

SUBSTANCE ABUSE IN THE ELDERLY. The Invisible Epidemic

Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain

Trigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS

Dr Alistair Dunn. General Practitioner Northland District Health Board Whangarei

OPIOID PAIN MEDICATION Agreement and Informed Consent

Less pain in my life helps me get back to living.

Doctor Discussion Guide

Pharmaceutical Misuse and its Challenges: Opioid Use in Ontario. Ontario Harm Reduction Conference Tara Gomes Tuesday January 31, 2012

Wisconsin Opioid Prescribing Guideline Draft Scope and purpose of the guideline

PROVIDER BULLETIN. Published by Wyoming Workers Compensation Medical Case Management Unit October 21, 2015

Talking with your doctor

Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic

Medication Guide. Medication Guide. Lazanda (La-ZAN-da) CII. (fentanyl) nasal spray 100 mcg, 400 mcg

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)

Opioids for persistent pain: Information for patients. The British Pain Society's

Implementing Pain and Opioid Management Guidelines in Primary Care Practice

MEDICATION MANAGEMENT AGREEMENT Pain Management Program Participation Agreement and Consent

Guide for Patients and Caregivers

Transcription:

Pain, Opioids and the EMR Dr. Gordon Schacter April 12, 2018

Faculty/Presenter Disclosure Faculty: Gordon Schacter Relationships with commercial interests: Grants/Research Support: None Speakers Bureau/Honoraria: Merck Frost Consulting Fees: KGK Science, Trial Management Group Other: London Middlesex Clinical Lead South West LHIN

Disclosure of Commercial Support No Commercial Support Potential for conflict(s) of interest: None

Mitigating Potential Bias No drug names are used. No specific EMR vendors names are used. Resources are provided.

Background Focus on Chronic Non-Cancer Pain not Acute Pain Resources: Guideline for opioid therapy and chronic noncancer pain. CMAJ May 08, 2017 189 (18) E659- E666; Centre for Effective Practice: Management of Chronic Non Cancer Pain Tool Health Quality Ontario Quality Standards: Opioid Prescribing for Chronic Pain 4

Management of Chronic Non-Cancer Pain Step 1: Comprehensive Assessment May need to be completed over more than one visit. Step 2: Management Options Select non-pharmacological and/or pharmacological therapies. (Non-opioids and opioids) Step 3: Initiate, Adapt and Evaluate Step 4: Refer as Appropriate 5

Step 1: Comprehensive Assessment People with chronic pain receive a comprehensive assessment, including consideration of their functional status and social determinants of health. A comprehensive assessment includes an assessment of the following The pain condition Any other medical conditions Psychosocial history, including history of trauma Mental health status Medication and substance use history Functional status Sleep patterns Past and current substance use disorder Past pain management and coping strategies 6

Comprehensive Assessment People with chronic pain receive a comprehensive assessment, including consideration of their functional status and social determinants of health. A comprehensive assessment includes an assessment of the following The pain condition Any other medical conditions Psychosocial history, including history of trauma Mental health status Medication and substance use history Functional status Sleep patterns Past and current substance use disorder Past pain management and coping strategies 7

Comprehensive Assessment The Pain Condition Identify pain diagnoses, e.g., OA, FM or NP If suspected Complex Regional Pain Syndrome (CRPS), consider urgent referral Pain Intensity Exacerbating and alleviating factors Character Systemic symptoms Duration 8

OPQRSTUV 9

Comprehensive Assessment The Pain Condition Past investigations/consultations Response to current/past treatments (consider whether trial was long enough to evaluate efficacy/side effects) Past medical history Current medications (including prescription, nonprescription, and natural products) 10

Comprehensive Assessment People with chronic pain receive a comprehensive assessment, including consideration of their functional status and social determinants of health. A comprehensive assessment includes an assessment of the following The pain condition Any other medical conditions Psychosocial history, including history of trauma Mental health status Medication and substance use history Functional status Sleep patterns Past and current substance use disorder Past pain management and coping strategies 11

Comprehensive Assessment Mental Health Status Current and past psychiatric history (e.g., depression PHQ-9[iii],anxiety GAD-7[iv], PTSD) Family psychiatric history Assess psychological yellow flags 12

PHQ-9 & GAD-7 13

Psychological Yellow Flags 14

Comprehensive Assessment People with chronic pain receive a comprehensive assessment, including consideration of their functional status and social determinants of health. A comprehensive assessment includes an assessment of the following The pain condition Any other medical conditions Psychosocial history, including history of trauma Mental health status Medication and substance use history Functional status Sleep patterns Past and current substance use disorder Past pain management and coping strategies 15

Comprehensive Assessment Substance use/abuse history Review history of substance use, abuse, and addiction (start with family history then personal history): Alcohol, cannabis, prescription medications, illicit drugs Attendance at an addiction treatment program May use Opioid Risk Tool, however, it has insufficient accuracy for risk stratification Use urine drug testing before starting opioid therapy. Consider annual urine drug testing (or more often, as appropriate) for the use of opioid medication and/or illicit drugs 16

Opioid Risk Tool 17

Comprehensive Assessment People with chronic pain receive a comprehensive assessment, including consideration of their functional status and social determinants of health. A comprehensive assessment includes an assessment of the following The pain condition Any other medical conditions Psychosocial history, including history of trauma Mental health status Medication and substance use history Functional status Sleep patterns Past and current substance use disorder Past pain management and coping strategies 18

Functional Status is a person s ability to perform activities of daily living, work, play, and socialization. Use a validated measure. e.g. Brief Pain Inventory 19

Brief Pain Inventory 20

Social Determinants of Health The social determinants of health include, but are not limited to, the following: Education Employment Family and social support Geographic location Housing Income Transportation and access to care 21

SDH Tablet-Based Tools 22

Setting Goals for Pain Relief and Function People with chronic pain set goals for pain relief and functional improvement in partnership with their health care professionals. These goals are evaluated regularly. Regular evaluation of goals Management goals should be documented and monitored over time. After initiating an opioid prescription, health care professionals should see the person with chronic pain for follow-up within 28 days. Progress toward management goals should then be reassessed within 2 to 3 months. 23

Patient Goals 24

Step 2: Management Options First-Line Treatment With Non-opioid Therapies People with chronic pain receive a multimodal combination of non-opioid pharmacotherapy and nonpharmacological therapies as first-line treatment. These therapies are ideally delivered through a multidisciplinary approach. 25

Non Pharmacological Therapies Physical Activity Psychological Therapy CBT Physical Therapy Self Management 26

Self Management LHIN 1 http://www.wechc.org/ health-condition LHIN 2 https://www.swself management.ca LHIN 3 http://www.wwself management.ca 27

Information on Harms of Opioid Use and Shared Decision-Making People with chronic pain, and their families and caregivers as appropriate, receive information about the potential benefits and harms of opioid therapy at the time of both prescribing and dispensing so that they can participate in shared decision-making. 28

Opioid Information - Handout Michael G. DeGroote National Pain Centre! Searc h... McMaster FHS NPC Home About Guidelines News Events Links Feedback Contact Canadian Guideline for Safe and E ffective Use of Opioids for Chronic Non-Cancer Pain Appendix B-4: Opioid Information for Patients [BACK] [TOC] [SITE MAP] NOTE: These messages could be used to create patient education materials. Messages for Patients Taking Opioids Note: Opioids are a group of similar medications that are used to help with pain there is more than one type of opioid and they have different names for example, Percocet, OxyContin, Tylenol No. 2, Tramacet. 1. Opioids are used to improve your ability to be active and reduce pain. You and your doctor will set goals and ensure the medication is effective in achieving the goals, e.g. improving your ability to do the things you did before pain prevented you. If you seem to benefit from the pain medication, your doctor will see you for follow-up visits to assess pain relief, any adverse effects, and your ability to meet your set activity goals. 2. There are side effects from opioids, but they can be mostly controlled with increasing your dose slowly. Common side effects include: nausea (28% of patients report it), constipation (26%), drowsiness (24%), dizziness (18%), dry-skin/itching (15%), and vomiting (15%). Side effects can be minimized by slowly increasing the dose of the drug and by using anti-nausea drugs and bowel stimulants. 3. Your doctor will ask you questions and discuss any concerns with you about your possibility of developing addiction. Addiction means that a person uses the drug to get high, and cannot control the urge to take the drug. Most patients do not get high from taking opioids, and addiction is unlikely if your risk for addiction is low: those at greatest risk have a history of addiction with alcohol or other drugs. 4. Opioids can help but they do have risks these can be managed by working cooperatively with your doctor. Take the medication as your doctor prescribed it. Don t drive while your dose is being gradually increased or if the medication is making you sleepy or feel confused. Only one doctor should be prescribing opioid medication for you don t obtain this medication from 29

Opioid Treatment Agreement 30

Step 3: Initiating Opioids for Chronic Pain After other multimodal therapies have been tried without adequate improvement in pain and function. No contraindications. Trial starts at the lowest effective dose Preferably not to exceed 50 mg morphine equivalents per day. In selected cases in which a higher dose is required for effective pain management and the person with chronic pain has discussed the increased risk of overdose and death with their health care professional, the dose may be titrated up to 90 mg morphine equivalents per day. 31

Calculating Morphine MEQ 32

Step 3: Evaluate 33

Other Important Standards Co-prescribing Opioids and Benzodiazepines People with chronic pain are not prescribed opioids and benzodiazepines at the same time. Opioid Use Disorder People prescribed opioids for chronic pain who are subsequently diagnosed with opioid use disorder have access to opioid agonist therapy. 34

Prescription Monitoring Systems Health care professionals who prescribe or dispense opioids have access to a real-time prescription monitoring system at the point of care. Clinical Connect DHDR, Narcotic Monitoring System Contact cswo@sw.ccac-ont.ca for more information 35

Tapering and Discontinuation People with chronic pain on long-term opioid therapy, especially those taking 90 mg morphine equivalents or more per day, are periodically offered a trial of tapering to a lower dose or tapering to discontinuation. 36

Opioid Tapering Guides 37

Opioid Tapering - EMR 38

Health Care Professional Education Health care professionals have the knowledge and skills to appropriately assess and treat chronic pain using a multidisciplinary, multimodal approach; appropriately prescribe, monitor, taper, and discontinue opioids; and recognize and treat opioid use disorder. 39

Health Care Professional Education http://www.swpca.ca/20/opioid_strategy/ Medical Mentoring for Addiction and Pain (OCFP) http://ocfp.on.ca/cpd/collaborative-networks Safer Opioid Prescribing (U of T) https://www.cpd.utoronto.ca/opioidprescribing/ OntarioMD Peer Leaders https://www.ontariomd.ca/products-andservices/peer-leader-program/overview Partnering for Quality (P4Q) http://www.partneringforquality.ca 40

Health Care Professional Education Centre for Effective Practice Academic Detailing https://effectivepractice.org/resources/acade mic-detailing-service/ LHIN 1: (Erie -St. Clair) Laura Dunn (laura.dunn@effectivepractice.org). LHIN 2: (South West) Nicole Seymore nicole.seymour@effectivepractice.org LHIN 3: pending 41

Questions 42

Thank you!